One Year Anniversary of Cancer Moonshot Reignition Brings Progress and Opportunity
American Cancer Society and ACS CAN statement on one-year anniversary of reignition of the Cancer Moonshot Initiative.
National Press Releases
Congress Prioritizes Cancer Research with $2.5 Billion Increase for NIH and $408 Million for NCI in FY 2023 Budget
WASHINGTON, D.C.—Early this morning Congress released a proposed FY 2023 funding deal that includes an increase of $2.5 billion for biomedical research funding at the National Institutes of Health (NIH), $408 million more for cancer research at the National Cancer Institute (NCI)
NCI Director Announces Personal Cancer Diagnosis
Statement from ACS and ACS CAN CEO Karen E. Knudsen on the announcement NCI Director Monica Bertagnolli has been diagnosed with breast cancer.
New Report: Cancer Survivors Face High Costs of Care and Debt Years After Treatment
WASHINGTON, D.C.—December 8, 2022—The costs of being diagnosed with cancer last long after the diagnosis and initial treatment putting cancer survivors at increased risk for lifelong financial hardship, according to a new report from the American Cancer Society Cancer Action Netw
Respect for Marriage Act Would Remove Barriers to Care Stemming from Discrimination
The U.S. Senate voted today on legislation that would help ensure marriage equality for same-sex and interracial couples and their families, as well as protect their ability to access employment benefits, such as health insurance.
ACS CAN Statement on Speaker Nancy Pelosi’s Leadership Role In The Fight Against Cancer
WASHINGTON, D.C.—Today House Speaker Nancy Pelosi announced she will not seek re-election to Democratic leadership.
In response, American Cancer Society Cancer Action Network President Lisa Lacasse issued the following statement:
Congress’ Year-End Must-Do List Should Prioritize Cancer Prevention, Detection, Research and Palliative Care
Cancer advocates are urging Congress to prioritize cancer prevention, detection, research and palliative care in any forthcoming year-end legislative package as a way to accelerate progress against the disease and end cancer as we know it.
ACS CAN Supports FDA’s Marketing Denial Order of Logic Technology Development
Washington, D,C. – The American Cancer Society Cancer Action Network (ACS CAN) and its partners submitted an amicus curiae (or friend-of-the-court) brief today in support of the U.S.
New Report: More Than 3 Million Youth Report Use of Tobacco Products
New data from the U.S. Food and Drug Administration (FDA) and the U.S. Centers for Disease Control and Prevention’s (CDC) National Youth Tobacco Survey (NYTS) finds more than 3 million youth report current use (past 30 days) of any tobacco product in 2022.
Third Circuit Upholds Marketing Denial Orders for Liquid Labs’ Flavored E-Cigarette Products; Products Must Be Removed from Shelves
The U.S. Court of Appeals for the Third Circuit ruled in favor of the U.S. Food and Drug Administration (FDA) in the case of Liquid Labs LLC v. FDA, upholding the agency’s marketing denial order (MDO) for Liquid Lab’s flavored e-cigarette products.